Advanced Accelerator Applications S.A. (NASDAQ: AAAP) announced that the European Commission (EC) has approved the marketing authorization of lutetium (177Lu) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News

Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) TumorsSeptember 29, 2017 9:15 AM Advanced Accelerator Applications (AAAP)/Novartis Deal Would Make Sense, But Timing is a Potential Obstacle; Worth $100+ in Takeover - JMPSeptember 28, 2017 3:12 PM After-Hours Stock Movers 09/27: (AAAP) (CHMA) (THO) Higher; (DXCM) (CMTL) (PIR) Lower (more...)September 27, 2017 6:01 PM Novartis (NVS) is Said to Consider Deal for Advanced Accelerator (AAAP) - BloombergSeptember 27, 2017 4:59 PM